These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37723518)

  • 1. A pediatric case series of catastrophic gastrointestinal complications of posttransplant lymphoproliferative disease with increasing incidence, high association with coronavirus disease 2019, higher mortality, and a plea for early endoscopy to prevent late fatal outcome.
    Keshtkar A; Karbasian F; Reihani H; Atighi F; Hedayati SB; Ataollahi M; Geramizadeh B; Dehghani SM
    J Med Case Rep; 2023 Sep; 17(1):396. PubMed ID: 37723518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus DNAemia in Iranian liver transplant recipients and assessment of its variation in posttransplant lymphproliferative disorder patients by quantitative polymerase chain reaction assay.
    Jamalidoust M; Geramizadeh B; Pouladfar G; Namayandeh M; Asaie S; Aliabadi N; Nikeghbalian S; Ziyaeyan M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():306-11. PubMed ID: 25894179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttransplant Lymphoproliferative Disorder Manifesting as Intestinal Epstein-Barr Virus-Positive Anaplastic Large-Cell Lymphoma in an Adult Renal Transplant Recipient.
    Börcek P; Özdemir BH; Özgün G; Haberal M
    Exp Clin Transplant; 2016 Nov; 14(Suppl 3):64-66. PubMed ID: 27805515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Fatal Complication of Liver Transplant: Posttransplant Lymphoproliferative Disease.
    Hizarcioglu-Gulsen H; Gumus E; Demir H; Saltik-Temizel IN; Varan A; Dincer HA; Dogrul AB; Ozen H
    Exp Clin Transplant; 2022 May; 20(Suppl 3):102-104. PubMed ID: 35570611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttransplant lymphoproliferative disorders and gastrointestinal manifestations of Epstein-Barr virus infection in children following liver transplantation.
    Cao S; Cox K; Esquivel CO; Berquist W; Concepcion W; Ojogho O; Monge H; Krams S; Martinez O; So S
    Transplantation; 1998 Oct; 66(7):851-6. PubMed ID: 9798693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Cytomegalovirus in the Development of Posttransplant Lymphoproliferative Disorders With or Without Epstein-Barr Virus Infection.
    Namayandeh M; Jamalidoust M; Pouladfar G; Zare M; Ziyaeyan M
    Exp Clin Transplant; 2022 Aug; 20(8):757-761. PubMed ID: 35037609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
    Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretransplant Epstein-Barr virus serostatus and incidence of posttransplant lymphoproliferative disorder in pediatric renal transplants.
    Rahimzadeh N; Otukesh H; Hoseini R; Riahifard A
    Exp Clin Transplant; 2013 Aug; 11(4):299-302. PubMed ID: 23905908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of Posttransplant Lymphoproliferative Disorder in Pediatric Patients With a Liver Transplant.
    Aliakbarian M; Dehghani SM; Geramizadeh B; Nikeghbalian S; Kasiri K; Kazemi K; Shamsaeefar A; Bahador A; Malekhosseini SA
    Exp Clin Transplant; 2015 Oct; 13(5):426-9. PubMed ID: 25232740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catastrophic gastrointestinal manifestations of post-transplant lymphoproliferative disorder.
    Hsu YC; Liao WC; Wang HP; Yao M; Lin JT
    Dig Liver Dis; 2009 Mar; 41(3):238-41. PubMed ID: 18083078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreasing incidence of symptomatic Epstein-Barr virus disease and posttransplant lymphoproliferative disorder in pediatric liver transplant recipients: report of the studies of pediatric liver transplantation experience.
    Narkewicz MR; Green M; Dunn S; Millis M; McDiarmid S; Mazariegos G; Anand R; Yin W;
    Liver Transpl; 2013 Jul; 19(7):730-40. PubMed ID: 23696264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience.
    Kogan-Liberman D; Burroughs M; Emre S; Moscona A; Shneider BL
    J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):445-9. PubMed ID: 11698761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus infection can affect lymphoproliferative disorders only as a cofactor for Epstein-Barr virus in liver transplant recipients: PTLD.Int survey.
    Khedmat H; Taheri S
    Exp Clin Transplant; 2012 Apr; 10(2):141-7. PubMed ID: 22432758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report.
    Dutta R; Miao SY; Phan P; Fernandez-Pol S; Shiraz P; Ho D; Mannis GN; Zhang TY
    J Med Case Rep; 2021 Mar; 15(1):170. PubMed ID: 33773605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression.
    Armitage JM; Kormos RL; Stuart RS; Fricker FJ; Griffith BP; Nalesnik M; Hardesty RL; Dummer JS
    J Heart Lung Transplant; 1991; 10(6):877-86; discussion 886-7. PubMed ID: 1661607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adapted treatment of Epstein-Barr virus infection to prevent posttransplant lymphoproliferative disorder after heart transplantation.
    Choquet S; Varnous S; Deback C; Golmard JL; Leblond V
    Am J Transplant; 2014 Apr; 14(4):857-66. PubMed ID: 24666832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.
    Newell KA; Alonso EM; Whitington PF; Bruce DS; Millis JM; Piper JB; Woodle ES; Kelly SM; Koeppen H; Hart J; Rubin CM; Thistlethwaite JR
    Transplantation; 1996 Aug; 62(3):370-5. PubMed ID: 8779685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
    Lones MA; Lopez-Terrada D; Shintaku IP; Rosenthal J; Said JW
    Arch Pathol Lab Med; 1998 Aug; 122(8):708-14. PubMed ID: 9701332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow involvement by lymphoproliferative disorders after solid-organ transplant.
    Akar Özkan E; Özdemir BH; Yılmaz Akçay E; Terzi A; Karakuş S; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():183-7. PubMed ID: 25894151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
    Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA
    Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.